Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Chemoprevention Trial - Anastrozole in the DCIS and Early Invasive Breast Cancer in Postmenopausal Women

NCT00256217 is registered in ClinicalTrials.gov with Rita Sanghvi, Mehta as lead sponsor.

NCT NCT00256217
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00256217 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Chemoprevention Trial - Anastrozole in the DCIS and Early Invasive Breast Cancer in Postmenopausal Women
Lead sponsor
Rita Sanghvi, Mehta
Phase
Phase 2
Overall status
Completed
Start date
September 21, 2004
Completion date
December 12, 2018
Enrollment
42 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dcis